ELAVL1 and colonic neoplasm: The addition of exosomes carrying HuR derived from colon cancer cells to BEAS-2B cells accelerated cell cycle progression through the G1/S transition; comparatively, cells treated with HuR-negative exosomes or the control exhibited G1 arrest.